A sensitive and simple procedure for detection and quantitation of circulating immune complexes (CIC) in human sera has been developed by utilizing Clq-microplate ELISA system.The utilization of an enzyme marker reagents, as opposed to 125 I-labled reagents is extremely advantageous, since it is safe, stable, economical, and fast.We applied this system to detect CIC in sera of 30 normal healthy controls and 83 patients with various diseases, including 23 cases of systemic lupus erythematosus (SLE), 25 cases of rtheumatoid arthritis (RA), 19 cases of malignant tumor (MT) (pulmonary carcinoma in 10 and hepatoma in 9) and 16 cases of acute type B hepatitis (HB). The average level of CIC (ug AHG eq/ml) in normal control group and four different patient groups were as follows: 12.7±6.12 for normal group, 29.54±15.24 for RA, 67.93±42.22 for SLE, 41.66±24.6 for MT and 27.34±17.79 for HB. The average of all the four different patient groups was significantly higher than that of the normal control group (P<0.001). Our results were some what better or equivalent to that by other methods in the literature. The conclusion that C1q microplate ELISA system is a safe, simple, economical and sensitive method for detecting circulating immune complexes is thus made.
A sensitive and simple procedure for detection and quantitation of circulating immune complexes (CIC) in human sera has been developed by utilizing Clq-microplate ELISA system.The utilization of an enzyme marker reagents, as opposed to 125 I-labled reagents is extremely advantageous, since it is safe, stable, economical, and fast.We applied this system to detect CIC in sera of 30 normal healthy controls and 83 patients with various diseases, including 23 cases of systemic lupus erythematosus (SLE), 25 cases of rtheumatoid arthritis (RA), 19 cases of malignant tumor (MT) (pulmonary carcinoma in 10 and hepatoma in 9) and 16 cases of acute type B hepatitis (HB). The average level of CIC (ug AHG eq/ml) in normal control group and four different patient groups were as follows: 12.7±6.12 for normal group, 29.54±15.24 for RA, 67.93±42.22 for SLE, 41.66±24.6 for MT and 27.34±17.79 for HB. The average of all the four different patient groups was significantly higher than that of the normal control group (P<0.001). Our results were some what better or equivalent to that by other methods in the literature. The conclusion that C1q microplate ELISA system is a safe, simple, economical and sensitive method for detecting circulating immune complexes is thus made.